EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $438,000 | +24.1% | 19,300 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $353,000 | -13.5% | 19,300 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $408,000 | +21.1% | 19,300 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $337,000 | -19.4% | 18,500 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $418,000 | +19.1% | 18,500 | +5.7% | 0.01% | 0.0% |
| Q4 2020 | $351,000 | -18.0% | 17,500 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $428,000 | +3.1% | 17,500 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $415,000 | +37.9% | 17,500 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $301,000 | -2.3% | 17,500 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $308,000 | -0.3% | 17,500 | 0.0% | 0.01% | -11.1% |
| Q3 2019 | $309,000 | -17.4% | 17,500 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $374,000 | -10.3% | 17,500 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $417,000 | +21.2% | 17,500 | 0.0% | 0.01% | +7.7% |
| Q4 2018 | $344,000 | +11.0% | 17,500 | 0.0% | 0.01% | +18.2% |
| Q3 2018 | $310,000 | -12.7% | 17,500 | +6.1% | 0.01% | -15.4% |
| Q2 2018 | $355,000 | -2.7% | 16,500 | 0.0% | 0.01% | -13.3% |
| Q1 2018 | $365,000 | -22.5% | 16,500 | +6.5% | 0.02% | -21.1% |
| Q4 2017 | $471,000 | +34.2% | 15,500 | +6.9% | 0.02% | +26.7% |
| Q3 2017 | $351,000 | -28.8% | 14,500 | -27.5% | 0.02% | -31.8% |
| Q2 2017 | $493,000 | +13.9% | 20,000 | 0.0% | 0.02% | +10.0% |
| Q1 2017 | $433,000 | +41.5% | 20,000 | -2.4% | 0.02% | +33.3% |
| Q4 2016 | $306,000 | +15.5% | 20,500 | -1.0% | 0.02% | +7.1% |
| Q3 2016 | $265,000 | +69.9% | 20,700 | +3.5% | 0.01% | +55.6% |
| Q2 2016 | $156,000 | +105.3% | 20,000 | +5.3% | 0.01% | +80.0% |
| Q1 2016 | $76,000 | -10.6% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $85,000 | -20.6% | 19,000 | 0.0% | 0.01% | -28.6% |
| Q3 2015 | $107,000 | +50.7% | 19,000 | 0.0% | 0.01% | +40.0% |
| Q2 2015 | $71,000 | +44.9% | 19,000 | 0.0% | 0.01% | +66.7% |
| Q1 2015 | $49,000 | +81.5% | 19,000 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $27,000 | -6.9% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $29,000 | -54.7% | 19,000 | 0.0% | 0.00% | -60.0% |
| Q2 2014 | $64,000 | -4.5% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $67,000 | -33.7% | 19,000 | +15.2% | 0.01% | -50.0% |
| Q4 2013 | $101,000 | +5.2% | 16,500 | 0.0% | 0.01% | -9.1% |
| Q3 2013 | $96,000 | +28.0% | 16,500 | 0.0% | 0.01% | +10.0% |
| Q2 2013 | $75,000 | – | 16,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |